Frontlight ResearchEarly access
CompletedNo phase
Mechanisms for Organ Dysfunction in Covid-19
Key facts
- Who runs it
- Uppsala University
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 380 people enrolled
- Started
- 12 Mar 2020
- Ended
- 31 Dec 2025
- Type of study
- Observational
- Record updated
- 12 January 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Admitted to intensive care
- suspected or verified COVID-19
Who cannot take part
- Under-age
- Pregnancy or breastfeeding
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The study aims to investigate organ dysfunction and biomarkers in patients with suspected or verified COVID-19 during intensive care at Uppsala University Hospital.
The group in the trial
- COVID-19
Patients with suspected or verified COVID-19 admitted to intensive care at Uppsala University Hospital
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Uppsala Intensive Care Study of Mechanisms for Organ Dysfunction in Covid-19
- Publications
- Body mass index is associated with pulmonary gas and blood distribution mismatch in COVID-19 acute respiratory failure. A physiological study.Frontiers in physiology, 2024
- Health-related quality of life after surviving intensive care for COVID-19: a prospective multicenter cohort study.Scientific reports, 2023
- Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19.Scientific reports, 2023
- Chest dual-energy CT to assess the effects of steroids on lung function in severe COVID-19 patients.Critical care (London, England), 2022
- Dehydration is associated with production of organic osmolytes and predicts physical long-term symptoms after COVID-19: a multicenter cohort study.Critical care (London, England), 2022
- A quantitative analysis of extension and distribution of lung injury in COVID-19: a prospective study based on chest computed tomography.Critical care (London, England), 2021
- Point of care ultrasound screening for deep vein thrombosis in critically ill COVID-19 patients, an observational study.Thrombosis journal, 2021
- The impact of viremia on organ failure, biomarkers and mortality in a Swedish cohort of critically ill COVID-19 patients.Scientific reports, 2021
- Record updated
- 12 January 2026